Institutional Ownership Catalyst Pharmaceuticals, Inc. (CPRX)
This table provides information about the institutional ownership of Catalyst Pharmaceuticals, Inc. (CPRX). We have compiled data on the 278 institutions that hold shares in the stock, with a total of 95.7 Million shares, which have been reported (via 13F filing form) to have a value of $1.55 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Black Rock Inc.
New York, NY |
May 10, 2024 Q1 2024 |
17,732,642
shares
|
$287 Million
0.01% of portfolio
|
Q1 2024
Added 12.07%
|
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
May 15, 2024 Q1 2024 |
9,130,817
shares
|
$148 Million
3.01% of portfolio
|
Q1 2024
Added 2.72%
|
|
|
State Street Corp
Boston, MA |
May 15, 2024 Q1 2024 |
8,152,902
shares
|
$132 Million
0.01% of portfolio
|
Q1 2024
Added 20.12%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
May 10, 2024 Q1 2024 |
7,980,661
shares
|
$129 Million
0.0% of portfolio
|
Q1 2024
Added 12.08%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
May 10, 2024 Q1 2024 |
2,737,657
shares
|
$44.3 Million
0.01% of portfolio
|
Q1 2024
Added 5.22%
|
|
|
Janus Henderson Group PLC
London, X0 |
May 15, 2024 Q1 2024 |
2,726,388
shares
|
$44.1 Million
0.02% of portfolio
|
Q1 2024
Added 139.45%
|
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2024 Q1 2024 |
2,508,152
shares
|
$40.6 Million
0.0% of portfolio
|
Q1 2024
Added 14.0%
|
|
|
Royce & Associates LP
|
May 13, 2024 Q1 2024 |
2,084,013
shares
|
$33.7 Million
0.31% of portfolio
|
Q1 2024
Added 19.56%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
May 13, 2024 Q1 2024 |
1,888,427
shares
|
$30.5 Million
0.05% of portfolio
|
Q1 2024
Added 18.22%
|
|
|
Morgan Stanley
New York, NY |
May 15, 2024 Q1 2024 |
1,798,856
shares
|
$29.1 Million
0.0% of portfolio
|
Q1 2024
Reduced 8.29%
|
|
|
Marshall Wace, LLP
London, X0 |
May 15, 2024 Q1 2024 |
1,683,951
shares
|
$27.2 Million
0.04% of portfolio
|
Q1 2024
New holding
|
|
|
Boston Partners
Boston, MA |
May 28, 2024 Q1 2024 |
1,506,930
shares
|
$24.4 Million
0.03% of portfolio
|
Q1 2024
Reduced 2.25%
|
|
|
Northern Trust Corp
Chicago, IL |
May 14, 2024 Q1 2024 |
1,429,748
shares
|
$23.1 Million
0.0% of portfolio
|
Q1 2024
Added 0.78%
|
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
May 15, 2024 Q1 2024 |
1,255,880
shares
|
$20.3 Million
0.09% of portfolio
|
Q1 2024
Reduced 2.38%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
May 15, 2024 Q1 2024 |
1,219,418
shares
|
$19.7 Million
0.0% of portfolio
|
Q1 2024
Added 1.91%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2024 Q1 2024 |
1,118,440
shares
|
$18.1 Million
0.0% of portfolio
|
Q1 2024
Added 119.26%
|
|
|
Voloridge Investment Management, LLC
Jupiter, FL |
May 15, 2024 Q1 2024 |
1,083,037
shares
|
$17.5 Million
0.06% of portfolio
|
Q1 2024
Added 72.08%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 08, 2024 Q1 2024 |
1,075,559
shares
|
$17.4 Million
0.0% of portfolio
|
Q1 2024
Added 12.47%
|
|
|
Kennedy Capital Management, Inc.
St Louis, MO |
May 15, 2024 Q1 2024 |
1,061,704
shares
|
$17.2 Million
0.37% of portfolio
|
Q1 2024
Added 101.12%
|
|
|
Opaleye Management Inc.
Boston, MA |
May 29, 2024 Q1 2024 |
1,004,355
shares
|
$16.2 Million
3.9% of portfolio
|
Q1 2024
Reduced 20.11%
|
|
|
Goldman Sachs Group Inc
New York, NY |
May 15, 2024 Q1 2024 |
1,001,281
shares
|
$16.2 Million
0.0% of portfolio
|
Q1 2024
Added 4.47%
|
|
|
Invesco Ltd.
Atlanta, GA |
May 14, 2024 Q1 2024 |
994,058
shares
|
$16.1 Million
0.0% of portfolio
|
Q1 2024
Added 8.09%
|
|
|
Lsv Asset Management
Chicago, IL |
May 06, 2024 Q1 2024 |
896,000
shares
|
$14.5 Million
0.03% of portfolio
|
Q1 2024
Reduced 27.2%
|
|
|
Jupiter Asset Management LTD
|
May 10, 2024 Q1 2024 |
809,360
shares
|
$13.1 Million
0.13% of portfolio
|
Q1 2024
Reduced 4.1%
|
|
|
Mesirow Institutional Investment Management, Inc.
Chicago, IL |
May 06, 2024 Q1 2024 |
719,104
shares
|
$11.6 Million
1.07% of portfolio
|
Q1 2024
New holding
|
|